APhA vs ASHP Midyear for Exhibitors

Side-by-side data and our editorial take on which conference is the right exhibit investment for your medical device.

By Buzzbox Media · Last reviewed August 3, 2026

If you exhibit medical devices, APhA and ASHP Midyear are likely both on your shortlist. Both serve overlapping clinical buyers, but the audience composition, booth economics, and exhibit floor experience differ in ways that materially affect ROI. APhA draws 5,000 attendees with an estimated all-in 10×10 of $7,500-$14,000, read from the published exhibitor prospectus. ASHP Midyear draws 20,000 attendees with no booth pricing published by the organizer. Below is the side-by-side data plus our editorial take on which conference fits which kind of exhibitor.

8.7 APhA
Score
Buzzbox Score 8.7 (Excellent)9.7 (Exceptional)
Event Details
Dates March 27-30, 2026December 6-9, 2026 (Exhibits: December 7-9)
Location Los Angeles, CA (Los Angeles Convention Center)Orlando, FL (Orange County Convention Center)
Scale largemega
Audience
Attendees 5,00020,000
Exhibitors n/an/a
Purchasing authority ~65%~65%
Effective buyers 3,25013,000
Costs
$/sqft n/an/a
10×10 space n/an/a
All-in estimate Est. $7,500-$14,000n/a
Cost per buyer $3.31n/a

Why exhibit at APhA

The premier meeting for community and ambulatory care pharmacists, featuring pharmacy owners and managers who make independent purchasing decisions for their practices. Three complimentary full registrations per booth ($3,000 value) offsets the booth cost significantly. Strong if you sell pharmacy software, point-of-care testing, or immunization supplies.

Why exhibit at ASHP Midyear

The largest pharmacy-specific meeting in the world, with 20,000+ attendees and a 28:1 attendee-to-exhibitor ratio that ensures strong foot traffic. Pharmacy directors and clinical pharmacists who influence formulary decisions, medication management systems, and compounding equipment purchases are well-represented. If you sell to pharmacy departments, this is the must-attend show.

Why skip APhA

If your target buyer is hospital pharmacy, ASHP Midyear is the better venue (4x the audience, hospital-system focus). APhA's student-heavy attendance means lower purchasing authority density compared to shows with mainly practicing pharmacists. Community pharmacy is a shrinking market segment.

Why skip ASHP Midyear

Heavy student and resident presence (Residency Showcase is a major feature) dilutes the purchasing-authority density. If your product targets physicians or nurses rather than pharmacists, this is the wrong audience.

APhA booth figures are estimates read from its published exhibitor prospectus ↗, not quotes. ASHP Midyear booth figures are estimates read from its published exhibitor prospectus ↗, not quotes. Confirm current pricing with each organizer before committing a budget.

Frequently Asked Questions

Does APhA or ASHP Midyear have more decision makers?

ASHP Midyear does, on our estimate: roughly 13,000 effective buyers against about 3,250 at APhA. Effective buyers multiplies total attendance by the share of attendees who hold purchasing authority, so ASHP Midyear works out to about 20,000 attendees at roughly 65% authority, and APhA to about 5,000 at roughly 65%. Both inputs are estimates drawn from organizer reporting and our own exhibitor research, so read the gap as directional rather than exact.

Want to add a third conference to this comparison?

Compare these conferences in our interactive tool →

Other conferences you might consider

Buzzbox Media is a medtech marketing agency with over 15 years in medtech. See our conference marketing.